Scarica l'app Stockscreener
3.22
1.58%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.17
Aprire:
$3.15
Volume 24 ore:
99,815
Relative Volume:
0.42
Capitalizzazione di mercato:
$128.16M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
29.27
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-0.92%
1M Prestazione:
-8.52%
6M Prestazione:
+55.56%
1 anno Prestazione:
+45.05%
Intervallo 1D:
$3.15
$3.29
Intervallo di 1 settimana:
$3.13
$3.36
Portata 52W:
$1.82
$3.71
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.22 | 126.17M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.90 | 119.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.67 | 82.71B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
844.41 | 52.43B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
336.19 | 45.01B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
362.14 | 39.23B | 4.98B | 69.60M | 525.67M | 0.5198 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Oramed Pharmaceuticals Restructures Scilex Notes via Warrant Deal - TipRanks
Scilex Grants Oramed New Warrant in Financing Agreement - TipRanks
What is the target price for Oramed Pharmaceuticals Inc. stockEarnings Risk Report & Low Risk High Win Rate Stock Picks - mfd.ru
Is Oramed Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Trade Ideas & AI Driven Price Predictions - mfd.ru
What are analysts’ price targets for Oramed Pharmaceuticals Inc.Quarterly Earnings Summary & Daily Entry Point Trade Alerts - mfd.ru
Will Oramed Pharmaceuticals Inc. (OJU1) stock recover faster than industryJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Aug Setups: What drives Oramed Pharmaceuticals Inc.’s stock priceJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January - MarketBeat
Geopolitics Watch: Can Oramed Pharmaceuticals Inc keep up with sector leaders2025 Earnings Surprises & Weekly Top Gainers Trade List - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc. stock undervalued right nowWeekly Gains Report & Safe Capital Investment Plans - mfd.ru
Support Test: Should you avoid Oramed Pharmaceuticals Inc stock right now2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Will Oramed Pharmaceuticals Inc. (OJU1) stock test record highs in 2025Weekly Earnings Recap & Reliable Momentum Entry Alerts - mfd.ru
Can Oramed Pharmaceuticals Inc. maintain sales growthJuly 2025 Levels & Real-Time Stock Price Movement Reports - mfd.ru
What drives Oramed Pharmaceuticals Inc.’s stock priceDividend Hike & Accurate Trade Setup Notifications - mfd.ru
What hedge funds are buying Oramed Pharmaceuticals Inc.2025 Winners & Losers & Verified Momentum Stock Alerts - mfd.ru
Lifeward Ltd. announced that it has received $0.525 million in funding - marketscreener.com
Aug Outlook: How much upside does Bakkt Holdings Inc Equity Warrant haveRecession Risk & Growth Focused Stock Pick Reports - baoquankhu1.vn
Bull Bear: What is the target price for Oramed Pharmaceuticals Inc. stockSwing Trade & Intraday High Probability Alerts - mfd.ru
NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN
Oramed Pharmaceuticals (NASDAQ:ORMP) & Demant A/S (OTCMKTS:WILYY) Head to Head Analysis - Defense World
Pullback Watch: Is Oramed Pharmaceuticals Inc stock a smart retirement pickQuarterly Profit Report & Daily Technical Forecast Reports - baoquankhu1.vn
What is the next catalyst for Oramed Pharmaceuticals Inc.July 2025 Sentiment & Stock Portfolio Risk Control - mfd.ru
Swing Trade: What is Oramed Pharmaceuticals Incs 5 year growth outlookJuly 2025 Market Mood & Breakout Confirmation Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals Achieves 60.85% Return, Leading Market Performance - Markets Mojo
OraTech to pioneer oral insulin with $75 million investment - MSN
Oramed Pharm completes warrant sale, boosting liquidity - MSN
NNDM Stock In Focus: Nano Dimension Pops A Poison Pill Days After Oramed Stake Build-Up - Stocktwits
Aug Update: What is ReTo Eco Solutions Incs book value per shareJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Jobs Data: Is Oramed Pharmaceuticals Inc stock good for income investors2025 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Oramed Shares Face Pressure Amid Strategic Pivot and Dividend Focus - AD HOC NEWS
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Large Increase in Short Interest - MarketBeat
Published on: 2026-01-17 10:34:33 - baoquankhu1.vn
Oramed Pharmaceuticals Inc.: - marketscreener.com
Oramed Pharm pivots with Lifeward strategic platform deal - TipRanks
Oramed Pharmaceuticals Signs Multiple Material Agreements - TradingView — Track All Markets
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Oramed to transfer oral drug delivery platform to Lifeward By Investing.com - Investing.com Nigeria
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal - Investing.com Nigeria
Buyout Rumor: Can Oramed Pharmaceuticals Inc maintain sales growthQuarterly Investment Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Oramed And Lifeward Reveal Strategic Deal - Pulse 2.0
Oramed to transfer oral drug delivery platform to Lifeward - Investing.com India
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal By Investing.com - Investing.com South Africa
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company - manilatimes.net
Oramed and Lifeward Announce Strategic Transaction - Financial Times
Lifeward Ltd. announced that it expects to receive $20 million in funding from Oramed Pharmaceuticals Inc. - marketscreener.com
Oramed Announces Shareholder Capital Return Following Strategic Windfall - AD HOC NEWS
Take Profit: Will Oramed Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Intraday Action & Growth Focused Investment Plans - Улправда
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Oramed Pharmaceuticals Inc Azioni (ORMP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kidron Miriam | Chief Scientific Officer |
Jan 22 '26 |
Option Exercise |
0.00 |
19,000 |
0 |
1,448,664 |
| Gabay Avraham | Chief Financial Officer |
Jan 22 '26 |
Option Exercise |
0.00 |
19,000 |
0 |
649,256 |
| KIDRON NADAV | President and CEO |
Jan 22 '26 |
Option Exercise |
0.00 |
109,000 |
0 |
3,355,238 |
0.34%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):